Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Organic solute transporter alpha (OSTα, encoded by SLC51A) is a critical component of the OSTα/OSTβ heterodimeric transporter complex, primarily responsible for sodium-independent facilitated transport of bile acids, conjugated steroids (e.g., estrone sulfate, dehydroepiandrosterone sulfate), and structurally related molecules across the basolateral membrane of epithelial cells, especially in the small intestine, liver, and kidney[1][2][4][6][8]. For functional transporter activity, OSTα must heterodimerize with OSTβ (SLC51B)[2][8]; individually, these proteins do not function as transporters. OSTα/OSTβ plays an essential role in the enterohepatic recirculation of bile acids—critical for lipid absorption—and protecting hepatocytes from bile acid toxicity during cholestatic stress[4][8]. Physiologically, gene expression is highest in tissues involved in bile acid handling (intestine, liver, kidney, adrenal gland), and the transporter is regulated by bile acid signaling through nuclear receptors (notably FXR)[4][8]. Genetic deficiency of SLC51A leads to progressive familial intrahepatic cholestasis type 6 (PFIC6), and upregulation of OSTα/β is observed in certain liver diseases such as NASH and cholestasis[6][8]. Interactions with, or inhibition by, drugs can be clinically significant in drug-induced liver injury and modulation of bile acid metabolism[8].
Facilitation of bile acid and steroid conjugate efflux/uptake via facilitated diffusion, mediated by the OSTα/OSTβ heterodimer Upregulation by farnesoid X receptor agonists (e.g., obeticholic acid induces OSTα/β expression)
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Organic solute transporter alpha (OSTα).